STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Clinical trials for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare tumors: drug duo shows promise
Disease control OngoingThis study tests whether combining two drugs, atezolizumab and bevacizumab, can shrink or control rare solid tumors. About 133 adults with cancers like appendix, anal, cervical, or mesothelioma will receive the drugs intravenously. The goal is to see if this immunotherapy approac…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
New combo therapy shows promise for mesothelioma patients
Disease control OngoingThis early-phase trial tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy before and after surgery is safe and feasible for people with resectable malignant pleural mesothelioma. 28 participants with stage I-III disease received the drug combinatio…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:03 UTC